Amdocsの空売り状況は、投資家がAmdocsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Amdocs (NASDAQ:DOX) 株価情報, 空売り情報

Amdocs

Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.

Amdocs Limited

Amdocs Ltd

Doximity Inc

News

DOCS

CORRECTION: Amdocs Ticker Is 'DOX'

WIIM

Amdocs shares are trading higher after the company reported better-than-expected Q2 EPS and sales.

<p>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) .</p>


Guidance

Amdocs expects Revenue for 2025 FY is expected to down by (10.9)% - (9.1)% YoY; Non-GAAP Diluted earnings per share is expected to up by 6.5%-10.5%YoY.

<p>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>), a leading provider of software and services to communications and media companies, today announced that it has extended a multi-year managed services agreement with M1 Limited (M1), a leading telco and digital services provider in Singapore, to manage M1's new cloud-native online <a href="https://pr.report/a3yb">charging platform</a> delivered earlier this year.</p>
<p>Under the agreement, Amdocs will provide augmented services for this converged (prepaid and postpaid as well as 4G and 5G) charging platform, including operational support and business enhancements. Amdocs will also ensure the system's stability and compliance with Singapore's Critical Information Infrastructure (CII) requirements as well as fulfillment of local regulatory requirements.</p>
<p>"At M1, we are dedicated to achieving operational excellence and providing innovative solutions that drive digital transformation in Singapore and the region," said Marko Cetkovic, Chief Digital Officer at M1. "Our extended collaboration with Amdocs will ensure that our new online charging platform operates at peak performance, enabling us to launch services faster, enhance efficiency and deliver unmatched value to our customers."</p>
<p>"We are proud to strengthen our relationship with M1 as they continue their mission of leveraging cutting-edge technology to evolve the telecommunications landscape in Singapore," said Anthony Goonetilleke, Group President of Technology and Head of Strategy at Amdocs. "As M1 introduces new services to market, Amdocs is committed to supporting their cloud-based scalability, agility and innovation, while improving their quality and efficiency."</p>
<p><strong>Supporting Resources</strong></p>
<p>Learn more about Amdocs <a href="https://pr.report/a3yc">amAIz Suite</a></p>
<p>Keep up with Amdocs news by visiting the company's <a href="https://pr.report/a3yd">website</a></p>
<p>Follow us on <a href="https://pr.report/a3ye">X</a>, <a href="https://pr.report/a3yf">Facebook</a>, <a href="https://pr.report/a3yg">LinkedIn</a> and <a href="https://pr.report/a3yh">YouTube</a></p>
<p><strong>About Amdocs</strong></p>
<p>Amdocs helps those who build the future to make it amazing. With our market-leading portfolio of software products and services, we unlock our customers' innovative potential, empowering them to provide next-generation communication and media experiences for both the individual end user and enterprise customers. Our employees around the globe are here to accelerate service providers' migration to the cloud, enable them to differentiate in the 5G era, and digitalize and automate their operations. Listed on the NASDAQ Global Select Market, Amdocs had revenue of $5.00 billion in fiscal 2024. For more information, visit <a href="https://pr.report/a3yi">www.amdocs.com</a></p>
<p><strong>Amdocs' Forward-Looking Statement</strong></p>
<p>This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs' growth and business results in future quarters and years. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general macroeconomic conditions, prevailing level of macroeconomic, business and operational uncertainty, including as a result of geopolitical events or other regional events or pandemics, changes to trade policies including tariffs and trade restrictions, as well as the current inflationary environment, and the effects of these conditions on the Company's customers' businesses and levels of business activity, including the effect of the current economic uncertainty and industry pressure on the spending decisions of the Company's customers. Amdocs' ability to grow in the business markets that it serves, Amdocs' ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company's products and services obsolete, security incidents, including breaches and cyberattacks to our systems and networks and those of our partners or customers, potential loss of a major customer, our ability to develop long-term relationships with our customers, our ability to successfully and effectively implement artificial intelligence and Generative AI in the Company's offerings and operations, and risks associated with operating businesses in the international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, Amdocs specifically disclaims any obligation to do so. These and other risks are discussed at greater length in Amdocs' filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2024, filed on December 17, 2024, and our Form 6-K furnished for the first quarter of fiscal 2025 on February 18, 2025.</p>


Contracts

M1 Enters Partnership With Amdocs To Manage Newly Delivered Cloud-Native Charging Platform

<p>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) is looking for Q3 Adj EPS of $1.68-$1.74 vs $1.77 analyst estimate. sees sales of $1.110 billion-$1.150 billion vs $1.13 billion analyst estimate.</p>


Amdocs Sees Q3 Adj EPS $1.68-$1.74 vs $1.77 Est; Sees Sales $1.110B-$1.150B vs $1.13B Est

<p>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) is looking for Q3 GAAP EPS of $1.30-$1.38 vs $1.57 analyst estimate..</p>


Amdocs Sees Q3 GAAP EPS $1.30-$1.38 vs $1.57 Est

<p>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) reported quarterly earnings of $1.78 per share which beat the analyst consensus estimate of $1.71 by 4.09 percent. This is a 14.1 percent increase over earnings of $1.56 per share from the same period last year.  The company reported quarterly sales of $1.13 billion which beat the analyst consensus estimate of $1.12 billion by 0.35 percent.  This is a 9.47 percent decrease over sales of $1.25 billion the same period last year.</p>


Earnings

Earnings Beats

Amdocs Q2 Adj. EPS $1.78 Beats $1.71 Estimate, Sales $1.13B Beat $1.12B Estimate

ACAD

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

ADEA

AEIS

AEVA

AGYS

AIOT

ALAB

ALAR

ALGM

AMPG

ARLO

ASGN

ASTI

ATOM

BASE

BBAI

BELFA

BELFB

BIGC

BLBX

BTCT

BZAI

CAMT

CCCS

CCRD

CGNX

CLMB

CMPO

COHU

CRDO

CRSR

CSIQ

CSPI

CTSH

CWAN

CXDO

DAKT

DAVA

DCBO

DGII

DIOD

DJCO

DMRC

DOCN

DOMO

EBON

EPAM

ETWO

EVCM

EVLV

EXFY

FARO

FCUV

FLEX

FSLR

GDYN

GRRR

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IDCC

INFA

INFY

INGM

INSG

IONQ

IPGP

ITRI

JAMF

Shares of broader tech companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

<p>With expertise in experience and digital engineering; data and generative AI, cloud, and quality engineering, Amdocs Studios' multi-disciplinary approach accelerates innovation, speeds go-to-market, and enables scalable transformation</p>


Amdocs Unveils Amdocs Studios At MWC 2025 To Accelerate Digital Transformation Across Industries

GOOG

Amdocs Announces An Initiative To Transform How Telecommunications Companies Operate, Maintain, And Optimize Critical 5G Network Ecosystems With AI Using Google Cloud's Vertex AI And Bigquery

CORRECTION: Doximity Ticker Is 'DOCS'

<p><i><strong>Greenland's largest telecom provider upgrades its business support systems (BSS) to enhance agility, unlock new revenue streams, and improve customer experience</strong></i></p>
<p><strong>JERSEY CITY, NJ / </strong><a href="https://www.accessnewswire.com/"><strong>ACCESS Newswire</strong></a><strong> / February 4, 2025 / </strong>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>), a leading provider of software and services for communications and media companies, announced today that Tusass, Greenland's largest telecom provider, has selected Amdocs to modernize its convergent charging and billing platform. This strategic upgrade marks a milestone in Tusass' digital transformation journey, paving the way for improved scalability, flexibility, and operational efficiency. As part of this transformation, Tusass will transition to a fully virtualized environment, equipping it to meet the growing demand for advanced services.</p>


Tusass Selects Amdocs To Modernize Monetization Platform And Unlock New Opportunities In Greenland

<p><strong>Amdocs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) announced its Q1 earnings on Tuesday, February 4, 2025 at 04:01 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Amdocs beat estimated earnings by 1.0%, reporting an EPS of $1.66 versus an estimate of $1.64.</p>
<p>Revenue was down $135.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 5.0% drop in the share price the next day.</p>
<p>Here's a look at Amdocs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.7</td>
<td>1.60</td>
<td>1.57</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.7</td>
<td>1.62</td>
<td>1.56</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Amdocs management provided guidance for Q2 2025, expecting earnings between $1.67 and $1.73 per share.</p>
<p>To track all earnings releases for Amdocs <a href="https://www.benzinga.com/quote/DOX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Amdocs Q1 Earnings Assessment

<p><strong>Amdocs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) announced its Q1 earnings on Tuesday, February 4, 2025 at 04:01 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Amdocs beat estimated earnings by 1.0%, reporting an EPS of $1.66 versus an estimate of $1.64.</p>
<p>Revenue was down $135.00 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the previous quarter, the company missed on EPS by $0.0, leading to a 5.0% drop share price change the next day.</p>
<p>Here's a look at Amdocs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.7</td>
<td>1.60</td>
<td>1.57</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.7</td>
<td>1.62</td>
<td>1.56</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Amdocs management provided guidance for Q2 2025, expecting earnings between $1.67 and $1.73 per share.</p>
<p>To track all earnings releases for Amdocs <a href="https://www.benzinga.com/quote/DOX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Amdocs Earnings Report: Q1 Overview

<p><strong>Amdocs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) released its Q1 earnings on Tuesday, February 4, 2025 at 04:01 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Amdocs beat estimated earnings by 1.0%, reporting an EPS of $1.66 versus an estimate of $1.64.</p>
<p>Revenue was down $135.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company missed on EPS by $0.0 in the last quarter, resulting in a 5.0% drop share price change the following day.</p>
<p>Here's a look at Amdocs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.7</td>
<td>1.60</td>
<td>1.57</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.7</td>
<td>1.62</td>
<td>1.56</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Amdocs management provided guidance for Q2 2025, expecting earnings between $1.67 and $1.73 per share.</p>
<p>To track all earnings releases for Amdocs <a href="https://www.benzinga.com/quote/DOX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Amdocs Q1

<p><strong>Amdocs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) released its Q1 earnings on Tuesday, February 4, 2025 at 04:01 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Amdocs beat estimated earnings by 1.0%, reporting an EPS of $1.66 versus an estimate of $1.64.</p>
<p>Revenue was down $135.00 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company missed on EPS by $0.0, resulting in a 5.0% drop change in the share price the following day.</p>
<p>Here's a look at Amdocs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.7</td>
<td>1.60</td>
<td>1.57</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.7</td>
<td>1.62</td>
<td>1.56</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Amdocs management provided guidance for Q2 2025, expecting earnings between $1.67 and $1.73 per share.</p>
<p>To track all earnings releases for Amdocs <a href="https://www.benzinga.com/quote/DOX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Amdocs: Q1 Earnings Insights

Amdocs Sees Q2 Adj. EPS $1.67-$1.73 Vs $1.68 Est; Revenue $1.105B-$1.145B Vs $1.120B Est.

<p><strong>Amdocs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) just disclosed its Q1 earnings on Tuesday, February 4, 2025 at 04:01 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Amdocs beat estimated earnings by 1.0%, reporting an EPS of $1.66 versus an estimate of $1.64.</p>
<p>Revenue was down $135.00 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company missed on EPS by $0.0 in the last quarter, resulting in a 5.0% drop share price change the following day.</p>
<p>Here's a look at Amdocs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.7</td>
<td>1.60</td>
<td>1.57</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.7</td>
<td>1.62</td>
<td>1.56</td>
<td>1.56</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.26B</td>
<td>1.25B</td>
<td>1.25B</td>
<td>1.25B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Amdocs management provided guidance for Q2 2025, expecting earnings between $1.67 and $1.73 per share.</p>
<p>To track all earnings releases for Amdocs <a href="https://www.benzinga.com/quote/DOX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Amdocs Q1

<p>Amdocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOX#NASDAQ">DOX</a>) reported quarterly earnings of $1.66 per share which beat the analyst consensus estimate of $1.63 by 1.84 percent. This is a 6.41 percent increase over earnings of $1.56 per share from the same period last year.  The company reported quarterly sales of $1.110 billion which missed the analyst consensus estimate of $1.114 billion by 0.33 percent.  This is a 10.84 percent decrease over sales of $1.245 billion the same period last year.</p>


Earnings Misses

Amdocs Q1 2025 Adj. EPS $1.66 Beats $1.63 Estimate, Sales $1.110B Miss $1.114B Estimate

Press Releases

Amdocs Expands Generative AI Suite, amAIz, with New Network Agents

Events

Amdocs Announces Q3F25 Investor Conference Schedule

Amdocs Limited Reports Second Quarter Fiscal 2025 Results

PLDT Goes Live with the Amdocs Customer Engagement Platform to Redefine Customer Experiences

Consumer Cellular Selects Amdocs connectX to Accelerate Launch of New Services

A1 Bulgaria Successfully Completes Major Platform Upgrade with Amdocs to Improve Customer Experience

CKH Innovations Opportunities Development Selects Amdocs MarketONE to Enhance its Telco Group's Digital Service Offerings

Japan's NTT InfraNet Successfully Deploys Advanced, Cloud-Native Platform, and Migrates Workloads with Amdocs

Singapore's M1 Collaborates with Amdocs to Manage Newly Delivered Cloud-Native Charging Platform

Comments

Amdocs

空売り

Amdocs (NASDAQ:DOX) 株価情報, 空売り情報

ニュース

パートナーシップ

ベンジンガ・グローバル